IL10 and neoplasm: Fortunately, after compatibility with JQC treatment in the given five ratios, the abnormalities of these two inflammatory mediators were significantly reversed, suggesting the anti-inflammatory reaction by at least TNF-α and IL-10 could partially involve the protection of compatibility with JQC against LGT-induced hepatotoxicity in tumor-bearing mice.